Abstract α-Smooth muscle actin (α-SMA) is used as a marker for a subset of activated fibrogenic cells, myofibroblasts, which are regarded as important effector cells of tissue fibrogenesis. We address whether α-SMA-expressing myofibroblasts are detectable in fibrotic muscles of mdx 5cv mice, a mouse model for Duchenne muscular dystrophy (DMD), and whether the α- 
Introduction
Tissue fibrosis is characterized by excessive deposition of extracellular matrix (ECM) proteins, including collagens and fibronectin. It is resulted from an uncontrolled wound-healing PLOS ONE | https://doi.org/10.1371/journal.pone.0191031 January 10, 2018 1 / 16 a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 muscle fibrosis associated with DMD is largely unknown [24] . Since targeting the α-SMA gene expression has been advocated for inhibiting the myofibroblast differentiation to treat tissue fibrosis [31] , it is important to understand whether myofibroblast is a significant player in the skeletal muscle fibrosis associated with DMD, and whether targeting α-SMA can be useful in treating the muscular dystrophy. In the present study, we addressed the presence of myofibroblasts in dystrophic muscles of the mdx 5cv mice, and determined the correlation of α-SMA expression with the fibrogenic function of intramuscular fibrogenic cells.
Materials and methods

Animals
Mdx 5cv mice were derived from the Jackson laboratory. ColI-GFP transgenic mice with the green fluorescent protein (GFP) expression driven by collagen I (α1) gene promoter to label collagen I α1 producing cells with high sensitivity and specificity were kindly provided by Dr. David Brenner [43] [44] [45] . Ccr2 -/-mice were originally kindly provided by Dr. Israel Charo [46] , which were backcrossed nine times with the C57BL/6J mice as previously described [47] . Mdx 5cv mice, instead of mdx mice, were used because the mdx 5cv mice are in the C57BL/6J
background, same as the Ccr2 -/-mice and ColI-GFP mice, while the mdx mice are in a different background. The mdx 5cv mice display more severe functional deficits and similar muscle pathology as compared with the mdx mice [48] . ColI-GFP/Mdx 5cv and ColI-GFP/Ccr2 -/-mice were generated by crossbreeding the ColI-GFP mice with the mdx 5cv and Ccr2 -/-mice, respectively, for identifying and studying ColI (GFP) + cells, which are mainly fibrogenic cells. All the study mice showed no gross abnormalities. Our study protocols were approved by the Institutional Animal Care and Use Committees at Icahn School of Medicine at Mount Sinai (New York, NY) and UT Southwestern Medical Center (Dallas, TX).
Acute muscle injury
To induce acute skeletal muscle injury, 100 μl 1.2% barium chloride (BaCl 2 ) was injected into the right quadriceps muscle of each wild-type (WT), Ccr2
-/-mouse (age 10-14 weeks). and ColI-GFP/Mdx 5cv mice were sacrificed at 3 or 6 months. Quadriceps and diaphragm muscles were collected and fresh frozen in liquid nitrogen-cooled isopentane, sectioned at 8 μm, stained with hematoxylin and eosin, and viewed under a bright field microscope.
Histopathological analysis
Immunostaining
Immunostaining was performed using the protocols published by us [16, [49] [50] [51] and others [35] . Briefly, frozen muscle sections were fixed with 4% paraformaldehyde for 30 minutes, blocked in 5% serum for 2 hours, and incubated overnight with the primary collagen III antibody (Southern Biotech, Birmingham, AL, USA), GFP antibody (Invitrogen, Carlsbad, CA, USA), or Cy3-conjugated mouse anti-α-SMA antibody (Clone 1A4, Sigma-Aldrich, St. Louis, MO, USA) [35, 52] . For collagen III immunostaining, the sections were then washed with PBS and incubated with FITC-conjugated secondary antibody for 2 hours. After stained with DAPI, slides were mounted with mounting medium and antibody binding was visualized under a fluorescent microscope.
Hydroxyproline assay
Muscles were snap-frozen and grounded in liquid nitrogen, followed by homogenization in distilled water. The muscle homogenates were then used for hydroxyproline assay using a kit purchased from Sigma-Aldrich (St. Louis, MO, USA) following the manufacturer's instruction.
Single-cell suspension preparation and cell sorting
Muscle single-cell suspension was prepared by collagenase/dispase digestion [49, 50, 53] . Briefly, each muscle was minced in 2.5 ml of digestion solution containing 1U/ml of collagenase B and 1U/ml of dispase II (Roche Diagnostics, Indianapolis, IN, USA) in PBS and incubated at 37˚C for 1 hour. The reaction was terminated by adding10 ml PBS with 10% FBS. The mixture was then filtered through a 70-μm cell strainer, and subjected to centrifugation twice at 250 g for 5 minutes. The pellets were combined, washed with PBS and centrifuged at 670 g for 10 minutes. The pellet was resuspended in 3 ml PBS, filtered through a 40- ) but without the GFP-Col1 transgene as negative controls to determine the cut-off for the GFP (Col1) + cell population.
Quantitative RT-PCR
Freshly sorted cells (1 million cells/sample) were lysed in the TRIzol reagent (Ambion, Grand Island, NY, USA). Total RNA was then purified and further cleaned up using the RNeasy Micro Kit (Qiagen, Hilden, Germany). Reverse transcription was performed using the SuperScriptTM II kit (Invitrogen, Frederick, MA, USA) following the manufacturer's instructions. The cDNA samples were then subjected to real-time PCR using the Sybr-green reagent and an Eppendorf Realpix4 cycler. The gapdh expression was used as an internal control. The reaction specificity was determined by product melting curves. The PCR products were verified by running 3% agarose gels. Data were analysed by ΔΔCt method and presented as Fold Changes.
The following PCR primers were used: col1α, forward 5'-GCTCCTCTTAGGGGCCACT-3' and reverse 5'-CCACGTCTCACCATTGGGG-3'; col3α, forward 5'-AACCTGGTTTCTTCT CACCCTTC-3' and reverse 5'-CCACGTCTCACCATTGGGG-3'; col6α, forward 5'-CGCC CTTCCCACTGACAA-3' and reverse 5'-GCGTTCCCTTTAAGACAGTTGAG-3'; fibronectin, forward 5'-AAACTTGCATCTGGAGGCAAACCC-3' and reverse 5'-AGCTCTGATCAGCA TGGACCACTT-3'; and α-sma, forward 5'-GACGTACAACTGGTATTGTG -3' and reverse 5'-TCAGGATCTTCATGAGGTAG -3'.
Western blot
Whole cell extracts were prepared by lysing freshly sorted cells (0.3 million/sample) using RIPA buffer (Protein Simple, San Jose, CA, USA) supplemented with protease inhibitor cocktail (Thermal Scientific, Rockford, IL, USA). The extracts were subjected to Western blot analysis following the protocol previously published [16] . Antibodies with high sensitivity and specificity against β-actin and α-SMA were purchased from Cell Signalling Technology (Danvers, MA, USA).
Statistical analyses
GraphPad (GraphPad software, Inc., La Jolla, CA, USA) was used for statistical analyses. All data were presented as mean ± SEM. Two-tailed Students t test was used when comparing two groups, and analysis of variance was performed with Bonferroni correction for multiple comparisons. A p value of <0.05 was considered statistically significant. 
Results
α-SMA
diaphragm or quadriceps muscles by immunostaining
We first addressed whether myofibroblasts with co-expression of collagen I and α-SMA were detectable by GFP (ColI)/α-SMA double immunostaining in fibrotic muscles of the ColI-GFP/ mdx 5cv mice. Endomysial fibrosis with mild thickening of endomysium was evident in both diaphragm and quadriceps muscles in the mdx 5cv mice at 3 months of age by H&E staining ( Fig 1A) and collagen III immunostaining ( Fig 1B) . The H&E staining also showed multifocal and scattered myonecrosis and endomysial inflammation ( Fig 1A) . The fibrosis was more severe in the diaphragm than in the quadriceps as measured by hydroxyproline assay (Fig 1C) . While the quadriceps fibrosis did not worsen at 6 months, the diaphragm fibrosis was progressive and became more severe at 6 months ( Fig 1C) . We performed GFP (ColI)/α-SMA double immunostaining in the diaphragm and quadriceps muscles of the ColI-GFP/mdx 5cv mice at 3 months (Fig 2A) and 6 months ( Fig 2B) . We used lung sections from the ColI-GFP mice with the lung fibrosis induced by bleomycin (kindly provided by Dr. Dean Sheppard) as a positive control (Fig 2C) , because these sections were known to contain GFP (ColI) + /α-SMA + myofibroblasts [35] . The double immunostaining showed many GFP (ColI) + cells in the diaphragm and quadriceps muscles of the ColI-GFP/mdx 5cv mice at 3 months (Fig 2A) and 6 months ( Fig   2B) . It also showed high α-SMA staining signals in the smooth muscle cells lining intramuscular blood vessel walls (Fig 2A and 2B ). While the GFP (ColI) + /α-SMA + myofibroblasts were detected in the fibrotic lung (Fig 2C) , they were not detected in the fibrotic diaphragm or quadriceps muscles (Fig 2A and 2B) . Therefore, myofibroblasts with co-expression of collagen I and α-SMA are not detectable by immunostaining in the fibrotic muscles of the mdx 5cv mouse model of DMD. [24, [55] [56] [57] [58] [59] [60] [61] . Studies by our lab and others have shown that infiltrating MOs/MPs not only phagocytose damaged muscle fibers to allow tissue repair, but also produce myotrophic growth factors to promote muscle regeneration [57, 58] . Mice deficient in CCR2 display poor muscle regeneration with persistent muscle fibrosis following acute injury [56] [57] [58] [59] . α-smooth muscle actin is not a marker of skeletal muscle fibrogenic cell activity
During normal acute skeletal muscle injury repair, there is transient muscle fibrosis with increased ECM protein deposition in endomysium, which provides a structural support for muscle repair. The transient fibrosis peaks at day 7, and then subsides [58] . While the endomysium of injured muscles at day 14 was minimally thickened in the wild-type (WT) mice, it was moderately thickened in the Ccr2 -/-mice as assessed by H&E staining and collagen III immunostaining ( Fig 3A) . The poor muscle regeneration in the Ccr2 -/-mice was evidenced by small regenerated fibers as compared with the WT controls (Fig 3A) . To further address whether α-SMA was expressed by collagen-producing fibrogenic cells to represent myofibroblasts in fibrotic muscles, we performed qRT-PCR (Fig 4A) and Western blot (Fig 4B-a, + fibrogenic cells sorted from lungs with fibrosis induced by belomycin (Fig 4B-b) .
Both mRNA and protein expression of α-SMA was detected in the fibrogenic cells from these fibrotic muscles. The α-SMA expression level was lower in the ColI-GFP/mdx 5cv diaphragm fibrogenic cells than in the quadriceps fibrogenic cells (Fig 4A and 4B ). This is in contrast to the more severe fibrosis seen in the diaphragm than in the quadriceps of the ColI-GFP/mdx 5cv mice (Fig 1) . The level of α-SMA protein expression was low in the ColI-GFP/mdx 5cv diaphragm fibrogenic cells but was similar in the ColI-GFP/mdx 5cv quadriceps fibrogenic cells as compared to that in the fibrotic lung fibrogenic cells (Fig 4B-b) .
Collagen gene expression was higher in the diaphragm fibrogenic cells than in the quadriceps fibrogenic cells in the ColI-GFP/mdx 5cv mice
We next examined the fibrogenic function of the ColI-GFP/mdx 5cv diaphragm and quadriceps fibrogenic cells by their ECM gene expression. The mRNA expression of the collagen I, collagen III and collagen VI genes was higher in the diaphragm fibrogenic cells than in the quadriceps fibrogenic cells, and the mRNA expression of the fibronectin gene was similar (Fig 4C) . Therefore, consistent with more severe fibrosis in the ColI-GFP/mdx 5cv diaphragm, the ColI-GFP/ mdx 5cv diaphragm fibrogenic cells exert a higher fibrogenic function than the quadriceps fibrogenic cells despite a low level of α-SMA expression by the diaphragm fibrogenic cells. α-SMA is not a marker for the fibrogenic function of fibrogenic cells in dystrophic muscles. α-smooth muscle actin is not a marker of skeletal muscle fibrogenic cell activity α-smooth muscle actin is not a marker of skeletal muscle fibrogenic cell activity 
Discussion
Myofibroblasts are a subset of activated fibrogenic cells with enhanced expression of ECM proteins and neo-expression of α-SMA [26, 31] . They regulate connective tissue remodelling and play an important physiological role in wound repair. Myofibroblasts can also play a significant pathological role in tissue fibrosis by their enhanced ECM production and contractile force generation to contribute to the activation of integrin-bound latent TGF-β1 [32, 33] . There are no specific markers for myofibroblasts [24, 26, 31] . Myofibroblasts are conventionally identified by co-expression of collagen I and α-SMA [27] [28] [29] [30] , although α-SMA is also expressed by smooth muscle cells. α-SMA has been used not only as a differentiation marker but also as a functional marker for myofibroblasts [31] [32] [33] . While the origins, activation, differentiation, and effector functions of myofibroblasts have been characterized in fibrotic disease models of several tissues, including lung, liver, kidney, and skin [27, 30, 31] , they have not been well-studied in the disease models of skeletal muscle fibrosis. By using the DMD mouse model, ColI-GFP/mdx 5cv mice, and the impaired acute skeletal muscle injury repair model,
ColI-GFP/Ccr2
-/-mice, our present study shows that myofibroblasts with co-expression of collagen I and α-SMA are present in the fibrotic skeletal muscles, but their α-SMA expression is not detectable by immunostaining. The α-SMA expression level does not correlate positively with the fibrogenic function of intramuscular fibrogenic cells or the severity of muscle fibrosis. Therefore, α-SMA is not a functional marker of fibrogenic cells in skeletal muscle fibrosis associated with DMD. Both α-SMA mRNA and protein are detectable by qRT-PCR and Western blot in collagen I-expressing cells purified from fibrotic muscles, which indicates that myofibroblasts are present in fibrotic muscles. However, the α-SMA [35, 52] . Although α-SMA has been conventionally used as a differentiation and functional marker of tissue myofibroblasts, the importance of α-SMA and α-SMA-expressing myofibroblasts in tissue fibrogenesis varies among different tissues [35] . It has been reported that unlike the presence of many ColI + /α-SMA + myofibroblasts in fibrotic liver with the fibrosis induced by CCl4, the α-SMA expression is detected by immunostaining only in a minority of collagen I-expressing cells in fibrotic lung and kidney with the fibrosis induced by bleomycin and unilateral ureter obstruction, respectively [35] . In the present study, we do not detect any cells with coexpression of collagen I and α-SMA in fibrotic muscles by immunostaining. This is consistent with the previous findings that myofibroblasts have been only identified in rare muscle diseases including nodular fasciitis and pseudomalignant myositis ossificans [40] [41] [42] . It has been shown that the α-SMA expression in myofibroblasts is not universally important in tissue fibrogenesis [35] . While fibroblasts with α-SMA expression did not contribute significantly to the lung fibrosis induced by bleomycin or the kidney fibrosis induced by unilateral ureter obstruction, they did contribute significantly to the liver fibrosis induced by CCl4, as the deletion of αv integrin in α-SMA-expressing cells protected against the experimental fibrosis in the liver but not in the lung or kidney [35] . Moreover, ColI + /α-SMA + and ColI + /α-SMA -fibroblasts from the fibrotic lung and kidney activated TGF-β equally [35] . These findings question the importance of α-SMA in the fibrogenic function of fibrogenic cells in lung and kidney, and strongly indicate that α-SMA is not a consistent functional marker of tissue fibrogenic cells [35] . The findings from our present study further support this notion. In contrast to the more severe fibrosis in the ColI-GFP/mdx 5cv diaphragm and the higher fibrogenic function of the ColI-GFP/mdx 5cv diaphragm fibrogenic cells, the α-SMA gene and protein expression levels are lower in the ColI-GFP/mdx 5cv diaphragm fibrogenic cells than in the ColI-GFP/ mdx 5cv quadriceps fibrogenic cells. The findings demonstrate that α-SMA is not a functional marker of fibrogenic cells in skeletal muscle fibrosis associated with the muscular dystrophy. In summary, myofibroblasts with co-expression of collagen I and α-SMA are present in fibrotic skeletal muscles, but they are not detectable by collagen I/α-SMA double immunostaining. α-SMA is not a marker of the fibrogenic function of intramuscular fibrogenic cells in the DMD mouse model. While targeting α-SMA gene expression has been advocated for inhibiting myofibroblast differentiation to reduce tissue fibrosis [31] , this strategy may not be useful in treating skeletal muscle fibrosis associated with DMD.
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